IAIM
WST icon

International Assets Investment Management’s West Pharmaceutical WST Stock Holding History

International Assets Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5K Sell
67
-16
-19% -$4.89K ﹤0.01% 1545
2026
Q1 		$21K Sell
83
-28
-25% -$6.97K ﹤0.01% 1486
2025
Q4 		$30.5K Buy
+111
New +$30.4K ﹤0.01% 1361
2024
Q4 		– Sell
-87
Closed -$26.1K – 1981
2024
Q3 		$26.1K Buy
87
+21
+32% +$6.43K ﹤0.01% 1281
2024
Q2 		$21.7K Buy
+66
New +$23.3K ﹤0.01% 1458
2023
Q2 		– Sell
-140
Closed -$48.5K – 1158
2023
Q1 		$48.5K Sell
140
-859
-86% -$251K 0.01% 681
2022
Q4 		$235K Buy
+999
New +$237K 0.02% 570
2021
Q2 		– Sell
-249
Closed -$70K – 1923
2021
Q1 		$70K Buy
249
+191
+329% +$54.7K 0.01% 846
2020
Q4 		$16K Buy
+58
New +$16.3K ﹤0.01% 1262

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

International Assets Investment Management's WST Position: Q2 2026 in Review

International Assets Investment Management reduced its West Pharmaceutical (WST) stake by 19% in Q2 2026, selling an estimated $4.89K and leaving 67 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

International Assets Investment Management first reported a position in WST in Q4 2020 and has held it in 9 quarters since. The position peaked at $235K in Q4 2022. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • International Assets Investment Management held 67 shares of West Pharmaceutical worth $24.5K as of Q2 2026.
  • International Assets Investment Management sold 16 West Pharmaceutical shares in Q2 2026, an estimated $4.89K.
  • West Pharmaceutical made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1545 holding.
  • International Assets Investment Management first reported a position in West Pharmaceutical in Q4 2020 and has held it in 9 quarters since.
  • International Assets Investment Management's West Pharmaceutical position peaked at $235K in Q4 2022.
  • 833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.